These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1859296)

  • 1. Acquired immunodeficiency syndrome. Cerebrospinal fluid findings in patients before and during long-term oral zidovudine therapy.
    Tartaglione TA; Collier AC; Coombs RW; Opheim KE; Cummings DK; Mackay SR; Benedetti J; Corey L
    Arch Neurol; 1991 Jul; 48(7):695-9. PubMed ID: 1859296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response.
    Brouwers P; Heyes MP; Moss HA; Wolters PL; Poplack DG; Markey SP; Pizzo PA
    J Infect Dis; 1993 Dec; 168(6):1380-6. PubMed ID: 8245522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine.
    de Gans J; Lange JM; Derix MM; de Wolf F; Eeftinck Schattenkerk JK; Danner SA; Ongerboer de Visser BW; Cload P; Goudsmit J
    AIDS; 1988 Feb; 2(1):37-40. PubMed ID: 3128994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.
    McKinney RE; Maha MA; Connor EM; Feinberg J; Scott GB; Wulfsohn M; McIntosh K; Borkowsky W; Modlin JF; Weintrub P
    N Engl J Med; 1991 Apr; 324(15):1018-25. PubMed ID: 1672443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS].
    de Gans J; Lange JM; Derix MM; de Wolf F; Ongerboer de Visser BW; Goudsmit J
    Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1656-60. PubMed ID: 3050555
    [No Abstract]   [Full Text] [Related]  

  • 6. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA; Jurriaans S; Weverling GJ; Burger DM; Hoetelmans RM; Roos MT; Maas J; Miedema F; Reiss P; Portegies P; de Wolf F; Lange JM
    Antivir Ther; 2001 Mar; 6(1):55-62. PubMed ID: 11417762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
    Tashima KT; Caliendo AM; Ahmad M; Gormley JM; Fiske WD; Brennan JM; Flanigan TP
    J Infect Dis; 1999 Sep; 180(3):862-4. PubMed ID: 10438381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decrease in human immunodeficiency virus antigen titer in the cerebrospinal fluid during treatment of AIDS patients with zidovudine].
    Claasen JN
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2122-3. PubMed ID: 3205324
    [No Abstract]   [Full Text] [Related]  

  • 9. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
    Lane HC; Falloon J; Walker RE; Deyton L; Kovacs JA; Masur H; Banks S; Kirk LE; Baseler MW; Salzman NP
    Ann Intern Med; 1989 Jul; 111(1):41-50. PubMed ID: 2735626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
    McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
    J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patients.
    Hoetelmans RM; Kraaijeveld CL; Meenhorst PL; Mulder JW; Burger DM; Koks CH; Beijnen JH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):131-6. PubMed ID: 9241112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
    Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
    Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment.
    Portegies P; Danner SA; Enting RH; Meilof J; de Wolf F; Goudsmit J
    Antivir Ther; 1996 Aug; 1(3):195. PubMed ID: 11322255
    [No Abstract]   [Full Text] [Related]  

  • 14. Study on didanosine concentrations in cerebrospinal fluid. Implications for the treatment and prevention of AIDS dementia complex.
    Burger DM; Kraayeveld CL; Meenhorst PL; Mulder JW; Hoetelmans RM; Koks CH; Beijnen JH
    Pharm World Sci; 1995 Nov; 17(6):218-21. PubMed ID: 8597780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-resistant variants of HIV-1 in brain.
    Di Stefano M; Norkrans G; Chiodi F; Hagberg L; Nielsen C; Svennerholm B
    Lancet; 1993 Oct; 342(8875):865. PubMed ID: 8104290
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.
    Gisslén M; Norkrans G; Svennerholm B; Hagberg L
    J Infect Dis; 1997 Feb; 175(2):434-7. PubMed ID: 9203666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF), alone and associated with zidovudine, on HIV-1 replication.
    Manfredi R; Re MC; Furlini G; Gorini R; Chiodo F
    New Microbiol; 1997 Oct; 20(4):345-50. PubMed ID: 9385605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection.
    Chiodi F; Albert J; Olausson E; Norkrans G; Hagberg L; Sönnerborg A; Asjö B; Fenyö EM
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):351-8. PubMed ID: 3196491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
    Foudraine NA; Hoetelmans RM; Lange JM; de Wolf F; van Benthem BH; Maas JJ; Keet IP; Portegies P
    Lancet; 1998 May; 351(9115):1547-51. PubMed ID: 10326538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of zidovudine administered by continuous infusion in children.
    Balis FM; Pizzo PA; Murphy RF; Eddy J; Jarosinski PF; Falloon J; Broder S; Poplack DG
    Ann Intern Med; 1989 Feb; 110(4):279-85. PubMed ID: 2643914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.